NCT00923572已完成不适用
Yasmin Regulatory Post Marketing Surveillance
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 777
- 主要终点
- Safety and efficacy in real practice
研究概览
简要总结
The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Women who need oral contraceptive
排除标准
- •Patient who belongs to contraindication listed on the product label.
研究组 & 干预措施
Group 1
干预措施: EE30/DRSP (Yasmin, BAY86-5131) (Drug)
结局指标
主要结局
Safety and efficacy in real practice
时间窗: After 6 cycle of treatment
次要结局
- Medical History(At initial visit)
- Demography(At initial visit)
- Administration period of Yasmin(After 6 cycle of treatment or at the point of withdrawan)
- Adverse Event / Serious AE collection(At point of the occurence)
- Patient's compliance(After 6 cycle of treatment or at the point of withdrawan)
研究者
相似试验
已完成
不适用
Regulatory Post Marketing Surveillance Study on YAZContraceptionPremenstrual SyndromeAcneNCT00998257Bayer770
已完成
不适用
Primovist Regulatory Post Marketing Surveillance (PMS)LiverNCT00924248Bayer4,358
已完成
不适用
Angeliq Regulatory Post Marketing SurveillancePostmenopausal PeriodOsteoporosis, PostmenopausalNCT01064453Bayer4,078
已完成
不适用
Eylea Post Marketing Surveillance(PMS)Macular DegenerationNCT01783925Bayer3,206
招募中
不适用
Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea PatientsHyperphosphatemiaNCT06186934Kyowa Kirin Korea Co., Ltd.600